TRRAP

Transformation/transcription domain-associated protein · Q9Y4A5 · TRRAP on Sugi Atlas →

0 patent compounds predicted against TRRAP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TRRAP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation PHASE2UNKNOWN
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia PHASE2ACTIVE_NOT_RECRUITING
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Itacitinib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib nanCOMPLETED
A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Involvement of Pollutants in Atopic Dermatitis and Psoriasis nanUNKNOWN
Steroid Treatment of Idiopathic Nephrotic Syndrome nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer nanUNKNOWN
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. nanUNKNOWN
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. nanUNKNOWN
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Exploratory Study of Rectal Mucus for Diagnosing Disease nanCOMPLETED
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TRRAP binder may also engage these)

ProteinNameSimilarity
A0A0R4ITC5 1.000 A0A0R4ITC5 →
O94915 0.992 O94915 →
Q8I8U7 0.992 Q8I8U7 →
Q9JLN9 0.987 Q9JLN9 →
Q5R6J0 0.987 Q5R6J0 →
P42346 0.986 P42346 →
MTOR Serine/threonine-protein kinase mTOR 0.986 landscape →
P21359 0.986 P21359 →
A1L1F4 0.985 A1L1F4 →
ECPAS Proteasome adapter and scaffold protein ECM29 0.985 landscape →
Q7TMY8 0.984 Q7TMY8 →
PDS5A Sister chromatid cohesion protein PDS5 homolog A 0.984 landscape →
Q6PDI5 0.984 Q6PDI5 →
F1R2X6 0.984 F1R2X6 →
Q5F3U9 0.983 Q5F3U9 →
C0H906 0.983 C0H906 →
Q6P4S8 0.983 Q6P4S8 →
F1QFR9 0.983 F1QFR9 →
F1MKX4 0.983 F1MKX4 →
B3NU52 0.983 B3NU52 →
HUWE1 E3 ubiquitin-protein ligase HUWE1 0.983 landscape →
XPO5 Exportin-5 0.983 landscape →
P97526 0.983 P97526 →
Q5TBA9 0.982 Q5TBA9 →
Q498H0 0.982 Q498H0 →
A4L9P7 0.982 A4L9P7 →
Q04690 0.982 Q04690 →
B1AY13 0.982 B1AY13 →
Q6A026 0.982 Q6A026 →
Q80TL7 0.981 Q80TL7 →